The Patent Finder

Antigen Express, Inc.

Also on record
Records under this name other than patents Antigen Express, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Antigen Express, Inc.

PatentTitleStatus Expires Confidence
US 7,935,350Ii-key/Her-2/neu hybrid cancer vaccine
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,889,143Ii-key/HER-2/neu hybrid cancer vaccine
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,748,130Human papillomavirus / Ii-Key hybrids and methods of use
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,179,645II-Key/Antigenic Epitope Hybrid Peptide Vaccines
Formerly held
Term ended
Term ended Nov 6, 2023 · High confidence
Term endedTerm ended Nov 6, 2023High confidence
US 9,289,487II-Key/Antigenic Epitope Hybrid Peptide Vaccines
Formerly held
Term ended
Term ended May 19, 2023 · Medium confidence
Term endedTerm ended May 19, 2023Medium confidence
US 7,205,274Hybrid Peptides Modulate the Immune Response
Term ended
Term ended Nov 27, 2020 · Medium confidence
Term endedTerm ended Nov 27, 2020Medium confidence
US 6,432,409Hybrid peptides modulate the immune response
Term ended
Term ended Sep 14, 2019 · From the USPTO record
Term endedTerm ended Sep 14, 2019From the USPTO record
US 8,815,249II-Key/Antigenic Epitope Hybrid Peptide Vaccines
Term ended
Term ended Sep 14, 2019 · Medium confidence
Term endedTerm ended Sep 14, 2019Medium confidence
US 7,541,334Hybrid peptides modulate the immune response
Lapsed on the fee record
Ended Jun 2, 2017 · From the USPTO record
Lapsed on the fee recordEnded Jun 2, 2017From the USPTO record
US 6,368,855MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expression
Term ended
Term ended Jun 11, 2016 · From the USPTO record
Term endedTerm ended Jun 11, 2016From the USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited